User:Crossroads/sandbox1
Possible useful sources for COVID-19 pandemic, later phases subheading:
WHO source Dec. 2025: https://www.who.int/publications/i/item/9789240117662
https://www.independent.co.uk/news/health/covid-pandemic-endemic-virus-b2714475.html
https://www.washingtonpost.com/wellness/2025/03/13/covid-endemic-pandemic-five-years/
https://www.bu.edu/articles/2024/is-covid-19-still-a-pandemic/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014506
McKoy, Jillian (8 March 2025). "COVID-19 in 2025: 'A Constant Threat, but a Manageable One'". School of Public Health. Boston University. Retrieved 31 December 2025.
"Get COVID-19 booster, though it's now considered endemic | UCLA Health".
Antia R, Halloran ME (October 2021). "Transition to endemicity: Understanding COVID-19". Immunity (Review). 54 (10): 2172–2176. doi:10.1016/j.immuni.2021.09.019. PMC 8461290. PMID 34626549.</ref>
"WHO downgrades COVID-19 pandemic, says it's no longer a global emergency". CBC. Retrieved 29 July 2023.
Charters, Erica; Heitman, Kristin (February 2021). "How epidemics end". Centaurus. 63 (1): 210–224. doi:10.1111/1600-0498.12370. ISSN 0008-8994. PMC 8014506. PMID 33821019.
"Principles of Epidemiology in Public Health Practice, Third Edition An Introduction to Applied Epidemiology and Biostatistics". Centers for Disease Control and Prevention. Retrieved April 19, 2018.
Ticona, Eduardo; Gao, George Fu; Zhou, Lei; Burgos, Marcos (2023-04-13). "Person-Centered Infectious Diseases and Pandemics". In Mezzich, Juan E.; Appleyard, James; Glare, Paul; Snaedal, Jon; Wilson, Ruth (eds.). Person Centered Medicine. Springer Nature. p. 465. ISBN 978-3-031-17650-0.
Cohen, Lily E.; Spiro, David J.; Viboud, Cecile (30 June 2022). "Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations". PLOS Pathogens. 18 (6) e1010591. doi:10.1371/journal.ppat.1010591. ISSN 1553-7374. PMC 9246171. PMID 35771775.
Baker, Rachel E.; Mahmud, Ayesha S.; Miller, Ian F.; Rajeev, Malavika; Rasambainarivo, Fidisoa; Rice, Benjamin L.; Takahashi, Saki; Tatem, Andrew J.; Wagner, Caroline E.; Wang, Lin-Fa; Wesolowski, Amy; Metcalf, C. Jessica E. (April 2022). "Infectious disease in an era of global change". Nature Reviews. Microbiology. 20 (4): 193–205. doi:10.1038/s41579-021-00639-z. ISSN 1740-1534. PMC 8513385. PMID 34646006.
Koelle, Katia; Martin, Michael A.; Antia, Rustom; Lopman, Ben; Dean, Natalie E. (2022-03-11). "The changing epidemiology of SARS-CoV-2". Science. 375 (6585): 1116–1121. Bibcode:2022Sci...375.1116K. doi:10.1126/science.abm4915. ISSN 1095-9203. PMC 9009722. PMID 35271324.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10145020/
https://publichealth.jhu.edu/2024/why-covid-cases-rise-every-summer
Harrison, Cameron M.; Doster, Jayden M.; Landwehr, Emily H.; Kumar, Nidhi P.; White, Ethan J.; Beachboard, Dia C.; Stobart, Christopher C. (10 February 2023). "Evaluating the Virology and Evolution of Seasonal Human Coronaviruses Associated with the Common Cold in the COVID-19 Era". Microorganisms. 11 (2): 445. doi:10.3390/microorganisms11020445. ISSN 2076-2607. PMC 9961755. PMID 36838410. After evaluating the biology, pathogenesis, and emergence of the human coronaviruses that cause the common cold, we can anticipate that with increased vaccine immunity to SARS-CoV-2, it will become a seasonal, endemic coronavirus that causes less severe disease in most individuals. Much like the common cold CoVs, the potential for severe disease will likely be present in those who lack a protective immune response or are immunocompromised.
Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A (June 2023). "The evolution of SARS-CoV-2". Nat Rev Microbiol (Review). 21 (6): 361–379. doi:10.1038/s41579-023-00878-2. PMID 37020110. S2CID 257983412. In the absence of eradication, the virus will likely become endemic, a process that could take years to decades. We will be able to establish that endemic persistence has been reached if the virus shows repeatable patterns in prevalence year on year, for example, regular seasonal fluctuations and no out-of-season peaks. The form this endemic persistence will take remains to be determined, and the eventual infection prevalence and disease burden will depend on the rate of emergence of antigenically distinct lineages, our ability to roll out and update vaccines, and the future trajectory of virulence (Fig. 4c)....Meanwhile, focusing on the epidemiology of the pathogen, it is important to bear in mind that the transition from a pandemic to future endemic existence of SARS-CoV-2 is likely to be long and erratic, rather than a short and distinct switch, and that endemic SARS-CoV-2 is by far not a synonym for safe infections, mild COVID-19 or a low population mortality and morbidity burden.
"From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic". www.who.int. World Health Organization. Retrieved 9 May 2023.
Heyward, Giulia; Silver, Marc (5 May 2023). "WHO ends global health emergency declaration for COVID-19". NPR. Retrieved 9 May 2023.
Rigby, Jennifer (8 May 2023). "WHO declares end to COVID global health emergency". Reuters. Retrieved 9 May 2023.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.